On the occasion of World Sickle Cell Day on 19 June, it is worth remembering that this genetic disease remains a major concern in sub-Saharan Africa, with a prevalence of up to 40% in heterozygous forms and 2% in homozygous forms. What is the current state of research and treatment for this disease, and what is its economic impact in Africa?
